How We Research & Publish

Editorial Policy

Every clinical, biochemical, and safety claim on theyetilife.com is held to the same standard: traceable to peer-reviewed literature. Flagged with an evidence tier, and reviewed before publication.

This page documents exactly how we research, write, fact-check, and update every article and page.

By the Yeti Life Research Team·Last reviewed April 2026·Review cadence: Quarterly

Shilajit content is YMYL — Your Money Your Life — under Google's quality framework. That means a reader's health and finances can be affected by what we publish.

We treat that seriously.

This policy is the written commitment behind every piece of content on the site. If we ever violate it, we want a reader to be able to cite the exact clause we broke.

The Evidence Hierarchy We Use

Four tiers · Assigned to every study we cite

Every research reference on the site carries an explicit evidence tier. Higher tier means stronger evidence for humans.

We never cite an animal study to support a human-outcome claim.

These tiers are enforced across our Shilajit Research Library, every pillar page, and every blog article.

1. Tier A · Human RCT.Randomised, controlled trial in humans, published in a peer-reviewed journal. Double-blind and placebo-controlled designs are the gold standard. Tier A is the only tier we accept for unqualified clinical claims.
2. Tier B · Systematic review or non-randomised human study.Comprehensive review of the human evidence base, commercial-product market survey, or heavy-metal contamination analysis. Strong but indirect — about the field, not a single controlled experiment.
3. Tier C · Animal or in vitro mechanistic study.Rodent behavioural tests, cell-culture biochemistry, mitochondrial assays. Useful for proposing a mechanism, not for claiming a human outcome.
4. Tier D · Foundational chemistry, method, or authoritative review.Papers that define what shilajit is — its constituents, its authenticity biomarkers, its pharmacopoeial specifications. The reference texts every other shilajit paper cites.

Source needs

What we accept · What we don't

A source must meet at least one of the following criteria to appear as a citation on this site:

1. Indexed in PubMed or a peer-reviewed journal.The study is searchable by PMID or DOI. Direct link to the source is included on the page so readers can audit it themselves.
2. Pharmacopoeial standard.Published in the Ayurvedic Pharmacopoeia of India (API), USP, EP, or equivalent national pharmacopoeia. Assay methods, heavy-metal limits, and microbial standards are all pharmacopoeia-referenced.
3. Independent accredited laboratory.Certificates of Analysis from Eurofins, SGS, Intertek, or NABL-accredited Indian labs. Analytical Report (A.R.) numbers are published so readers can verify directly with the lab.
4. Government or regulatory authority.AYUSH Ministry, FSSAI, or equivalent regulatory guidance — named explicitly when cited.

What we do not accept as citations:

• Conference abstracts or unreviewed preprints
• Brand-commissioned "white papers" with no independent peer review
• Testimonials, influencer endorsements, or case reports without published data
• Studies on humic acid or peat extracts that do not test shilajit directly
• Secondary citations — we read the primary source before citing

Three Editorial Standards

Non-negotiable rules · Applied to every page

Three rules govern every claim on the site. Every article, every pillar page, and every product description is written against these standards.

1. Tier before headline.We never cite an animal study to claim a human effect. Every clinical claim is backed by a Tier A or Tier B paper from our research library — or it carries an explicit caveat naming the evidence gap. If we can't cite a Tier A or B source, we don't make the claim.
2. Purified material only.Studies that used unpurified or undefined shilajit are noted but not used to support product claims. Our batches are tested to the same pharmacopoeial standard as the PrimaVie material used in the Pandit, Keller, and Das RCTs. Claims from studies using unpurified material are explicitly flagged as such.
3. Absence of evidence is absence of claim.No published human RCT exists for shilajit treating anxiety, diabetes, thyroid imbalance, PCOS, or weight loss. We do not make those outcome claims. We cite the mechanistic papers where they exist and flag the clinical gap explicitly rather than silently inherit industry hype.

Fact-Checking Workflow

Four-step process · Applied before publication and on every update

Every article goes through four checks before it is published. Every refresh cycle re-runs the same checks on existing content.

1. Primary-source verification.Every cited study is read in full (not just abstract). Sample size, study design, dose, duration, and primary endpoint are confirmed against the PubMed entry. Secondary citations are traced back to the primary source before inclusion.
2. Tier assignment.Each citation is assigned its evidence tier (A/B/C/D) against the hierarchy above. Tier is displayed alongside the citation so readers can judge quality without our editorial gloss.
3. Claim-to-source cross-check.Each paragraph containing a clinical claim is matched back to a specific study. If a claim cannot be tied to a Tier A or Tier B source, it is either rewritten with a caveat or removed.
4. Counter-evidence search.For every positive finding we cite, we search PubMed for contradicting evidence. Where contradictions exist (e.g. Jaiswal 1992 vs no human anxiety RCT), we note both.

Authorship & Review

Who writes · Who reviews · Who takes responsibility

Content on theyetilife.com is produced by the Yeti Life Research Team. The team keeps the Shilajit Research Library as the single source of truth for every clinical and biochemical claim on the site.

Articles are produced by the research team, reviewed for evidence alignment against the library. Checked for adherence to the three editorial standards above before publication.

The team is based in India (Yeti Life Pvt Ltd, Noida). Direct contact for editorial questions: care@theyetilife.com.

We are expanding the authorship model in 2026 to include individually named contributors and a qualified medical reviewer (AYUSH-registered Ayurvedic practitioner or MD). This page will be updated when those signatories come on board.

Until then, the Yeti Life Research Team is the collective author of record.

Content Update & Correction Policy

Quarterly review · Immediate correction

Content is kept on two tracks:

1. Quarterly review cycle.Every pillar page (Shilajit Guide, Our Sourcing, Lab Results, Research Library) is reviewed every three months. We audit PubMed for new shilajit papers, update the "Last reviewed" date, refresh citations, and correct any stale stats or regulatory references.
2. Immediate correction on error discovery.If a factual error is identified — whether by us, a reader, or an outside researcher — we correct the page within 48 hours of verification. If the correction materially changes a claim, we note the change and date at the bottom of the page. We do not silently edit.

Retraction policy: if a cited study is formally retracted from its journal. We remove the reference and update any claim that depended on it within 7 days.

The removal is logged in the library's change history.

Conflict of Interest Disclosure

Full transparency · No hidden agenda

The Yeti Life Research Team is used by Yeti Life Pvt Ltd. This manufactures and sells Himalayan shilajit resin.

This is a direct commercial interest in the shilajit category.

We manage this conflict through three practices:

• No pay-to-cite.Studies are selected based on the evidence hierarchy, not on whether they favour our product. Studies that flag problems in the shilajit category (Wilson 2011 on commercial variability, the 2025 thallium contamination paper) are cited prominently because they are scientifically important.
• Explicit competitor coverage.We publish honest comparisons to other brands (Rasayanam, Kapiva, Dabur, Patanjali, Baidyanath, Man Matters, Himalaya, Upakarma, Zandu, BetterAlt). These comparisons cite public data where it exists and flag missing data where it doesn't. We do not remove a competitor comparison if it embarrasses us.
• "Absence of claim" enforcement.We do not claim outcomes we cannot support with Tier A or B evidence, even when claiming them would be commercially advantageous.

External sponsorships, affiliate relationships, or paid placements on the site are disclosed inline where they happen. At the time of this writing (April 2026), no such relationships exist.

Medical Disclaimer

Not a substitute for medical advice

Content on theyetilife.com is educational. It is not medical advice, diagnosis, or treatment.

Shilajit, like any supplement, interacts with medications and may not be appropriate for every person — especially pregnant or breastfeeding women. People with haemochromatosis, people on thyroid or anticoagulant medications, and those with chronic kidney or liver disease.

Always consult a qualified healthcare professional (MD, DO, registered Ayurvedic practitioner, or pharmacist) before starting, stopping, or changing any supplement regimen. If you experience an adverse reaction, stop the supplement immediately and seek medical attention.

Feedback & Error Reporting

We fix errors · Publicly

If you spot an error — whether it's a miscited study, a broken PubMed link, a dosage figure that disagrees with the source paper, or a claim that exceeds the evidence — we want to know.

Email care@theyetilife.com with the URL, the specific claim, and what you believe the correct information is. We will verify, correct if confirmed, and credit the reporter in our internal change log (not on the page.

Unless the reporter prefers public credit).